Saudi Arabia is among the top 10 G20 countries in cancer survival rates
In a medical achievement reflecting the rapid development of the Kingdom's healthcare system, the Saudi Health Council that Saudi Arabia has secured a place among the top ten G20 in terms of survival rates for the most common types of cancer. This global ranking is not merely a statistical indicator, but rather an international testament to the efficiency and quality of medical services provided to patients in the Kingdom.
Promising figures and high recovery rates
Detailed data from the Saudi Cancer Registry shows a remarkable improvement in recovery rates, with the Kingdom recording survival rates that rival those of medically advanced countries. The figures are as follows:
- Prostate cancer: It achieved the highest survival rate of 82% , a figure that reflects the development of surgical and therapeutic methods.
- Breast cancer: The survival rate reached 76% , indicating the success of early detection programs and ongoing awareness.
- Colorectal cancer: A survival rate of 61% .
These results are the fruit of integrated efforts to improve the patient's treatment journey, from accurate diagnosis to providing the latest global treatment protocols.
The Saudi Cancer Registry: 30 Years of Accurate Monitoring
This achievement cannot be discussed without acknowledging the pivotal role of the Saudi Cancer Registry . Established in 1412 AH (1992 CE), this registry has become a cornerstone in the fight against the disease. Over nearly 30 years, it has documented a total of 406,119 cancer cases , making it a comprehensive national reference for epidemiological data. This vast database not only serves for documentation but also acts as a strategic tool for decision-makers to guide health policies and allocate medical resources efficiently.
Vision 2030 and the transformation of the health sector
This progress is part of a broader context related to the Kingdom’s Vision 2030 and the Health Sector Transformation Program, which aims to restructure the sector into a comprehensive and efficient healthcare system. The Kingdom has invested heavily in medical infrastructure, specialized cancer centers, and advanced radiotherapy and gene therapy technologies. Furthermore, the focus has shifted from treatment to prevention, through enhanced early detection programs that significantly increase survival rates, as clearly demonstrated by breast cancer statistics.
International recognition and global credibility
The success of the Saudi Cancer Registry has not been limited to the Kingdom; it has also garnered widespread international recognition and accreditation. It has been classified as a “high-quality” registry by prestigious organizations such as the World Health Organization (WHO) , the International Agency for Research on Cancer (IARC), and the American Cancer Society. This recognition confirms that the data issued by the Kingdom possesses the highest levels of accuracy and reliability, making the Kingdom an active partner in global cancer research.
In conclusion, this ranking within the G20 is a strong indication that the Kingdom is on the right track towards achieving global leadership in healthcare, thereby providing a better and longer life for its citizens and residents.
